Annual Total Liabilities
$420.60 K
+$214.00 K+103.58%
September 1, 2024
Summary
- As of February 18, 2025, DRUG annual total liabilities is $420.60 thousand, with the most recent change of +$214.00 thousand (+103.58%) on September 1, 2024.
- During the last 3 years, DRUG annual total liabilities has fallen by -$80.00 thousand (-15.98%).
- DRUG annual total liabilities is now -62.76% below its all-time high of $1.13 million, reached on September 30, 2022.
Performance
DRUG Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$420.60 K
+$290.20 K+222.55%
September 1, 2024
Summary
- As of February 18, 2025, DRUG quarterly total liabilities is $420.60 thousand, with the most recent change of +$290.20 thousand (+222.55%) on September 1, 2024.
- Over the past year, DRUG quarterly total liabilities has dropped by -$223.30 thousand (-34.68%).
- DRUG quarterly total liabilities is now -62.76% below its all-time high of $1.13 million, reached on September 30, 2022.
Performance
DRUG Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
DRUG Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +103.6% | -34.7% |
| 3 y3 years | -16.0% | -34.7% |
| 5 y5 years | +272.9% | -34.7% |
DRUG Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.8% | +103.6% | -62.8% | +222.6% |
| 5 y | 5-year | -62.8% | +272.9% | -62.8% | +462.3% |
| alltime | all time | -62.8% | +272.9% | -62.8% | +462.3% |
Bright Minds Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $420.60 K(+103.6%) | $420.60 K(+222.5%) |
| Jun 2024 | - | $130.40 K(-79.2%) |
| Mar 2024 | - | $626.00 K(-2.8%) |
| Dec 2023 | - | $643.90 K(+211.7%) |
| Sep 2023 | $206.60 K(-81.7%) | $206.60 K(-62.7%) |
| Jun 2023 | - | $554.50 K(-27.9%) |
| Mar 2023 | - | $769.30 K(+79.2%) |
| Dec 2022 | - | $429.30 K(-62.0%) |
| Sep 2022 | $1.13 M | $1.13 M(+277.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $299.00 K(-62.8%) |
| Mar 2022 | - | $803.80 K(+109.3%) |
| Dec 2021 | - | $384.00 K(-23.3%) |
| Sep 2021 | $500.60 K(+343.8%) | - |
| Sep 2021 | - | $500.60 K(+92.2%) |
| Jun 2021 | - | $260.40 K(-19.7%) |
| Mar 2021 | - | $324.20 K(+333.4%) |
| Dec 2020 | - | $74.80 K(-33.7%) |
| Sep 2020 | $112.80 K | - |
| Sep 2020 | - | $112.80 K |
FAQ
- What is Bright Minds Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual total liabilities year-on-year change?
- What is Bright Minds Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly total liabilities year-on-year change?
What is Bright Minds Biosciences annual total liabilities?
The current annual total liabilities of DRUG is $420.60 K
What is the all time high annual total liabilities for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual total liabilities is $1.13 M
What is Bright Minds Biosciences annual total liabilities year-on-year change?
Over the past year, DRUG annual total liabilities has changed by +$214.00 K (+103.58%)
What is Bright Minds Biosciences quarterly total liabilities?
The current quarterly total liabilities of DRUG is $420.60 K
What is the all time high quarterly total liabilities for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly total liabilities is $1.13 M
What is Bright Minds Biosciences quarterly total liabilities year-on-year change?
Over the past year, DRUG quarterly total liabilities has changed by -$223.30 K (-34.68%)